Regeneron Pharmaceuticals (REGN) Revenue Growth (1y) (2010 - 2026)
Regeneron Pharmaceuticals (REGN) Revenue Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,899.61 Bn | 65,899.33 Bn | - | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 471.67 Bn | 466.88 Bn | 1.35 Bn | 35.46% |
| 5 | Vertex Pharmaceuticals | 122.32 Bn | 115.07 Bn | 2.59 Bn | 7.82% |
| 6 | Regeneron Pharmaceuticals | 70.04 Bn | 61.29 Bn | 3.31 Bn | 19.04% |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - | - |
| 8 | Argenx Se | 55.93 Bn | 50.74 Bn | 1.41 Bn | 64.03% |
| 9 | Alnylam Pharmaceuticals | 37.55 Bn | 34.54 Bn | 959.66 Mn | 96.43% |
| 10 | Revolution Medicines | 37.18 Bn | 37.18 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.04% |
| Dec 31, 2025 | 2.51% |
| Sep 30, 2025 | 0.90% |
| Jun 30, 2025 | 3.62% |
| Mar 31, 2025 | -3.70% |
| Dec 31, 2024 | 10.33% |
| Sep 30, 2024 | 10.65% |
| Jun 30, 2024 | 12.32% |
| Mar 31, 2024 | -0.54% |
| Dec 31, 2023 | 3,334.30% |
| Sep 30, 2023 | 14.53% |
| Jun 30, 2023 | 10.53% |
| Mar 31, 2023 | 6,224.20% |
| Dec 31, 2022 | -97.98% |
| Sep 30, 2022 | -14.96% |
| Jun 30, 2022 | -44.40% |
| Mar 31, 2022 | -98.02% |
| Dec 31, 2021 | 104.37% |
| Sep 30, 2021 | 50.51% |
| Jun 30, 2021 | 163.24% |